This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Has Brainsway’s TMS therapy been tested?
Brainsway* Deep TMS therapy has been tested in over 60 clinical studies, for various clinical indications, in leading institutions worldwide. The FDA* has cleared this TMS therapy for treatment resistant depression and it is currently available in the U.S., Europe, and South America.